Insights from murine models suggest that immune dysregulation following acute Coxsackie viral myocarditis drives the progression to dilated cardiomyopathy, highlighting potential targets for immunomodulatory therapies.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating from murine models; does not support immunomodulatory therapy or practice change in viral myocarditis.
Summary Coxsackie viral myocarditis is a common disease, yet idiopathic dilated cardiomyopathy is a less common consequence. Insights gained from studying the Coxsackie virus B-3 murine model of myocarditis has led to the hypothesis that an acute Coxsackie viral myocarditis can result in persistent, non-viral mediated cellular responses that result in a chronic inflammatory state leading to progressive myocyte loss and ultimate development of dilated cardiomyopathy. Although the evidence linking myocarditis to dilated cardiomyopathy is circumstantial in man, the identification of defects in immunoregulation may provide the impetus to further research into the pathogenesis and ultimately the development of more rational therapies directed at modulating immune responses to alter the natural history of clinical dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
OʼConnell et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: